Antibiotic prophylaxis for gynecologic cancer surgery

Area of Science:

• Gynecologic Oncology
• Surgical Infectious Diseases
• Pharmacology

Background:

• Prophylactic antibiotics are crucial in elective gynecologic cancer surgery.
• Overuse of antibiotics necessitates establishing optimal administration durations.
• Minimizing antibiotic exposure while ensuring patient safety is a key clinical goal.

Purpose of the Study:

• To determine the optimal duration of prophylactic antibiotic administration in gynecologic cancer surgery.
• To evaluate the impact of 1-day versus extended antibiotic prophylaxis on postoperative outcomes.
• To reduce unnecessary antibiotic use in this patient population.

Main Methods:

• Retrospective analysis of clinical records from patients undergoing radical hysterectomy or staging for gynecologic cancer.
• Comparison of postoperative outcomes between a 1-day antibiotic prophylaxis group and a >1-day group.
• Outcomes assessed included surgical site infection (SSI), urinary tract infection (UTI), hospital stay, and catheterization/drainage duration.

Main Results:

• A total of 139 patients were analyzed; 79 received 1-day prophylaxis and 60 received >1-day.
• The 1-day group showed significantly less blood loss (P=0.007) and shorter hospital stays (P=0.039).
• No significant differences were observed in SSI or UTI rates between the groups (P=0.903 and P=0.393, respectively).

Conclusions:

• One-day administration of first-generation cephalosporins is appropriate for gynecologic cancer surgery.
• This duration effectively prevents common post-surgical complications like wound infections and UTIs.
• The findings support optimizing antibiotic prophylaxis duration to prevent overuse in gynecologic oncology.